hans_wijers

GSK appoints Hans Wijers to its Board as a non-executive director

pharmafile | January 28, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, hans Wijers 

GSK has confirmed the appointment of Hans Wijers to its Board as a non-executive director with effect from April. 

The appointment is subject to shareholder approval at the firm’s annual general meeting. Wijers is currently a non-executive director and chairman designate of Heineken, one of the world’s largest brewers.  

He is also currently deputy chairman and non-executive director of Royal Dutch Shell. Previously, Wijers was chief executive and chairman at AkzoNobel, a world-leading paints and coating company and a major producer of speciality chemicals, a position he held for 10 years. 

Advertisement

Prior to joining Akzo Nobel, Wijers held positions as minister for economic affairs for the government of the Netherlands as well as in the private sector with the Boston Consulting Group.

Commenting on the appointment, Sir Christopher Gent, chairman of GSK, said:

“I am delighted to welcome Hans to the Board. His broad business experience, including as chief executive of AkzoNobel, together with his economic and political knowledge will enable him to make a significant contribution to the future success of GSK.”

Related Content

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

GSK’s Exdensur (depemokimab), a twice-yearly biological medicine, has received approval from the UK Medicines and …

Multiple myeloma treatment approved in Japan

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by Japan’s Ministry of Health, Labour and …

The Gateway to Local Adoption Series

Latest content